2019
Addressing Comorbidities in Difficult Asthma
Kwah J, Peters A, Khatri S. Addressing Comorbidities in Difficult Asthma. Respiratory Medicine 2019, 55-74. DOI: 10.1007/978-3-030-20812-7_4.Peer-Reviewed Original ResearchTreat asthmaAsthma controlAspirin-exacerbated respiratory diseaseChronic oral corticosteroidsPoor asthma controlVocal cord dysfunctionObstructive sleep apneaLaryngopharyngeal reflux diseaseManagement of patientsSignificant symptomatic reliefOral corticosteroidsDifficult asthmaReflux diseaseAllergic rhinitisChronic rhinosinusitisCord dysfunctionSymptomatic reliefComorbid conditionsSleep apneaNasal polypsRespiratory diseaseAsthmaCorticosteroidsPatientsDisease
2017
Trends in Omalizumab Utilization for Asthma: Evidence of Suboptimal Patient Selection
Jeffery MM, Shah ND, Karaca-Mandic P, Ross JS, Rank MA. Trends in Omalizumab Utilization for Asthma: Evidence of Suboptimal Patient Selection. The Journal Of Allergy And Clinical Immunology In Practice 2017, 6: 1568-1577.e4. PMID: 28958746, DOI: 10.1016/j.jaip.2017.07.034.Peer-Reviewed Original ResearchConceptsOmalizumab initiationAsthma controlICS-LABAPatient selectionLow adherenceBetter asthma controlCohort of nonusersSuboptimal patient selectionPoor asthma controlLow adherence ratesPatient-level characteristicsLarge US databaseMedicare Advantage beneficiariesAsthma biologicsExacerbation frequencyOmalizumab useIncident useComparison cohortICS/Medication adherenceAdherence ratesPrevalent usersAdministrative claimsAsthmaUtilization trends
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply